gw8510 and tamoxifen

gw8510 has been researched along with tamoxifen in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, CG; Li, J; Li, MY; Li, XQ; Li, ZN; Shu, Y; Wang, S; Zhao, XH	1

Other Studies

1 other study(ies) available for gw8510 and tamoxifen

Article	Year
Acquired tamoxifen resistance is surmounted by GW8510 through ribonucleotide reductase M2 downregulation-mediated autophagy induction. Biochemical and biophysical research communications, 2020, 07-30, Volume: 528, Issue:3 Topics: Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Autophagy; Breast Neoplasms; Cell Line, Tumor; Down-Regulation; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; Indoles; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Ribonucleoside Diphosphate Reductase; Tamoxifen; Xenograft Model Antitumor Assays	2020

Article

Year

Acquired tamoxifen resistance is surmounted by GW8510 through ribonucleotide reductase M2 downregulation-mediated autophagy induction.

Biochemical and biophysical research communications, 2020, 07-30, Volume: 528, Issue:3

Topics: Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Autophagy; Breast Neoplasms; Cell Line, Tumor; Down-Regulation; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; Indoles; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Ribonucleoside Diphosphate Reductase; Tamoxifen; Xenograft Model Antitumor Assays

2020